Cleary, Megana; Ndhlovu, Lishomwa C.b; Sacha, Jonah B.a,c. Stem cell transplantation and allogeneic immunity: post treatment control or HIV cure?. Current Opinion in HIV and AIDS ():10.1097/COH.0000000000000892, October 22, 2024. | DOI: 10.1097/COH.0000000000000892
Archives: Publications
Publications
Silencing the transcriptionally active HIV reservoir to improve treatment outcomes
Prigann, J., Tavora, R., Furler O’Brien, R.L. et al. Silencing the transcriptionally active HIV reservoir to improve treatment outcomes. Nat Microbiol (2024). https://doi.org/10.1038/s41564-024-01816-5
Partner Protections in HIV Cure-Related Trials Involving Analytical Treatment Interruption: Updated Toolkit to Mitigate HIV Transmission Risk
Li, S., Nguyen, K., & Yang, H. (2024). The cancer-immune setpoint in HIV cure. Cell Reports Medicine, 5(8), 100923. https://doi.org/10.1016/j.xcrm.2024.100923
Retro-age: A unique epigenetic biomarker of aging captured by DNA methylation states of retroelements
Jang, Y., & Kim, Y. (2024). Retro-age: A unique epigenetic biomarker of aging captured by DNA methylation states of retroelements. Aging Cell, 23(2), e14288. https://doi.org/10.1111/acel.14288
Open Access Transcriptional and methylation outcomes of didehydro-cortistatin A use in HIV-1–infected CD4+ T cells
Liu, Y., Zhao, X., Li, Y., Ma, X., & Lee, K. (2023). Transcriptional and methylation outcomes of didehydro-cortistatin A use in HIV-1–infected CD4+ T cells. Life Science Alliance, 7(10), e202402653. https://www.life-science-alliance.org/content/7/10/e202402653
Brief Report: Comparative Analysis of Pre-existing HIV Drug Resistance Mutations in Proviral DNA Using Next-Generation Sequencing and Routine HIV RNA Genotyping
Gaitan NC, D’Antoni ML, Acosta RK, Gianella S, Little SJ, Chaillon A. Brief Report: Comparative Analysis of Pre-existing HIV Drug Resistance Mutations in Proviral DNA Using Next-Generation Sequencing and Routine HIV RNA Genotyping. J Acquir Immune Defic Syndr. 2023 Jul 1;93(3):213-218. doi: 10.1097/QAI.0000000000003195. PMID: 36961945; PMCID: PMC10272101.
The single-cell opioid responses in the context of HIV (SCORCH) consortium
Ament, S.A., Campbell, R.R., Lobo, M.K. et al. The single-cell opioid responses in the context of HIV (SCORCH) consortium. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02620-7
People with HIV at the end-of-life and their next-of-kin/loved ones are willing to participate in interventional HIV cure-related research
Ndukwe SO, Patel H, Shelton B, Concha-Garcia S, Dullano C, Solso S, Hendrickx S, Riggs PK, Villa TJ, Kaytes A, Taylor J, Little SJ, Lessard D, Arora AK, Costiniuk CT, Eskaf S, Smith DM, Gianella S, Dubé K. People with HIV at the end-of-life and their next-of-kin/loved ones are willing to participate in interventional HIV cure-related research. AIDS. 2024 Feb 1;38(2):235-243. doi: 10.1097/QAD.0000000000003754. Epub 2023 Oct 17. PMID: 37861674.
Vulnerability in Biomedical Research: A Historical Reflection and Practical Implications for HIV Cure-Related Research
Rao E, Taylor J, Kaytes A, Concha-Garcia S, Riggs PK, Smith DM, Dubé K, Gianella S. Vulnerability in Biomedical Research: A Historical Reflection and Practical Implications for HIV Cure-Related Research. AIDS Res Hum Retroviruses. 2024 Jan;40(1):22-27. doi: 10.1089/AID.2022.0136. Epub 2023 Jun 21. PMID: 37227023; PMCID: PMC10790546.
Ribosomal profiling of human endogenous retroviruses in healthy tissues
Dopkins N, Singh B, Michael S, Zhang P, Marston JL, Fei T, Singh M, Feschotte C, Collins N, Bendall ML, Nixon DF. Ribosomal profiling of human endogenous retroviruses in healthy tissues. BMC Genomics. 2024 Jan 2;25(1):5. doi: 10.1186/s12864-023-09909-x. PMID: 38166631